BACKGROUND: Maintaining appropriate glycemic control in critically ill patients reduces morbidity and mortality. The use of point-of-care (POC) glucose devices is necessary to obtain rapid results at the patient's bedside. However, the devices should be thoroughly tested in the intended population before implementation. The use of POC glucose meters in critically ill patients has been questioned both in the literature and by regulatory agencies. The aim of this study was to determine if the ACCU-CHEK® Inform II system (Roche Diagnostics) POC glucose meter demonstrated the desired accuracy and precision, as defined by Clinical and Laboratory Standards Institute guideline POCT12-A3, in a large number of critically ill patients from multiple intensive care settings at two academic medical centers. METHODS: A total of 1200 whole blood meter results from 600 patients were compared with central laboratory plasma values. Whole blood aliquots from venous samples were used to obtain duplicate meter results with the remaining sample being processed to obtain plasma for central laboratory testing within 5 min of meter testing. RESULTS: A total of 1185 (98.8%) of the new meter's glucose values were within ± 12.5% (± 12 mg/dl for values ≥ 100 mg/dl) of the comparative laboratory glucose values, and 1198 (99.8%) were within ± 20% (± 20 mg/dl for values <100 mg/dl). CONCLUSIONS: Considering the large number of patients from numerous critical care units examined, the new glucose meter system appears to have sufficient analytic accuracy for use in critically ill patients.
BACKGROUND: Maintaining appropriate glycemic control in critically illpatients reduces morbidity and mortality. The use of point-of-care (POC) glucose devices is necessary to obtain rapid results at the patient's bedside. However, the devices should be thoroughly tested in the intended population before implementation. The use of POC glucose meters in critically illpatients has been questioned both in the literature and by regulatory agencies. The aim of this study was to determine if the ACCU-CHEK® Inform II system (Roche Diagnostics) POC glucose meter demonstrated the desired accuracy and precision, as defined by Clinical and Laboratory Standards Institute guideline POCT12-A3, in a large number of critically illpatients from multiple intensive care settings at two academic medical centers. METHODS: A total of 1200 whole blood meter results from 600 patients were compared with central laboratory plasma values. Whole blood aliquots from venous samples were used to obtain duplicate meter results with the remaining sample being processed to obtain plasma for central laboratory testing within 5 min of meter testing. RESULTS: A total of 1185 (98.8%) of the new meter's glucose values were within ± 12.5% (± 12 mg/dl for values ≥ 100 mg/dl) of the comparative laboratory glucose values, and 1198 (99.8%) were within ± 20% (± 20 mg/dl for values <100 mg/dl). CONCLUSIONS: Considering the large number of patients from numerous critical care units examined, the new glucose meter system appears to have sufficient analytic accuracy for use in critically illpatients.
Authors: G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: Harold L Lazar; Marie McDonnell; Stuart R Chipkin; Anthony P Furnary; Richard M Engelman; Archana R Sadhu; Charles R Bridges; Constance K Haan; Rolf Svedjeholm; Heinrich Taegtmeyer; Richard J Shemin Journal: Ann Thorac Surg Date: 2009-02 Impact factor: 4.330
Authors: David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan Journal: Clin Chem Date: 2011-05-26 Impact factor: 8.327
Authors: Simon Finfer; Bette Liu; Dean R Chittock; Robyn Norton; John A Myburgh; Colin McArthur; Imogen Mitchell; Denise Foster; Vinay Dhingra; William R Henderson; Juan J Ronco; Rinaldo Bellomo; Deborah Cook; Ellen McDonald; Peter Dodek; Paul C Hébert; Daren K Heyland; Bruce G Robinson Journal: N Engl J Med Date: 2012-09-20 Impact factor: 91.245
Authors: Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe Journal: Lancet Date: 2009-01-26 Impact factor: 79.321
Authors: Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez Journal: Diabetes Care Date: 2009-05-08 Impact factor: 19.112
Authors: Moritoki Egi; James S Krinsley; Paula Maurer; Devendra N Amin; Tomoyuki Kanazawa; Shruti Ghandi; Kiyoshi Morita; Michael Bailey; Rinaldo Bellomo Journal: Intensive Care Med Date: 2016-02-03 Impact factor: 17.440
Authors: Brooke M Katzman; Brandon R Kelley; Gayle R Deobald; Nikki K Myhre; Sean A Agger; Brad S Karon Journal: J Diabetes Sci Technol Date: 2020-06-07
Authors: Brad S Karon; Leslie J Donato; Chelsie M Larsen; Lindsay K Siebenaler; Amy E Wells; Christina M Wood-Wentz; Mary E Shirk-Marienau; Timothy B Curry Journal: Anesthesiology Date: 2017-09 Impact factor: 7.892